Status:
UNKNOWN
Evaluation of the Performance of Self-monitoring Optimized by Therapeutic Education in the Recurrence of Wet Age-related Macular Degeneration (AMD)
Lead Sponsor:
Clinique Beau Soleil
Conditions:
Age-related Macular Degeneration
Eligibility:
All Genders
50+ years
Brief Summary
Monocentric and prospective study, evaluating the benefit of self-monitoring optimized by therapeutic education either by the environmental Amsler or the Amsler grid according to the patient's choice ...
Eligibility Criteria
Inclusion
- Affiliation to a social security scheme
- Patient agreeing to participate in the process of therapeutic education.
- Centrofoveal fixation with visual acuity\> 2/10
- Antecedent of at least one recurrence so that the patient is aware of the notion of recurrent chronic disease
- Intravitreal injection antecedent less than 6 months ago
Exclusion
- Vulnerable people
- Majors subject to legal protection or unable to express their consent
- Arterial emboli disorders of less than three months such as myocardial infarction, stroke
Key Trial Info
Start Date :
July 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 10 2021
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04032808
Start Date
July 10 2019
End Date
July 10 2021
Last Update
February 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique Beau Soleil
Montpellier, France, 34070